US OptionsDetailed Quotes
RIGL250117C17000
- 0.75
- -0.25-25.00%
15min DelayClose Jan 7 16:00 ET
0.75High0.75Low
0.75Open1.00Pre Close4 Volume11 Open Interest17.00Strike Price300.00Turnover77.63%IV3.86%PremiumJan 17, 2025Expiry Date0.09Intrinsic Value100Multiplier9DDays to Expiry0.66Extrinsic Value100Contract SizeAmericanOptions Type0.5452Delta0.1866Gamma18.99Leverage Ratio-0.0473Theta0.0022Rho10.35Eff Leverage0.0108Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
No comment yet